BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12489754)

  • 21. Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide?
    Mathie RT; Ralevic V; Moore KP; Burnstock G
    Hepatology; 1996 Jan; 23(1):130-6. PubMed ID: 8550032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
    Resende AC; Pimentel AM; de Moura RS
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
    Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
    Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detrimental effects of nitric oxide on mesenteric circulation during endotoxaemia and its reversal by aminoguanidine.
    Yorganci K; Sayek I; Ismailoglu UB; Sahin-Erdemli I
    Eur J Surg; 2000 Nov; 166(11):888-93. PubMed ID: 11097157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baroreceptor reflex function in rats submitted to chronic inhibition of nitric oxide synthesis.
    Vasquez EC; Cunha RS; Cabral AM
    Braz J Med Biol Res; 1994 Mar; 27(3):767-74. PubMed ID: 8081303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
    El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
    Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide at the CVLM is involved in the attenuation of the reflex bradycardia in renovascular hypertensive rats.
    de Castro UG; de Sousa GG; Machado Rdo P; Isoldi MC; Silva ME; Nadu AP; Sousa LE; Santos RA; Campagnole-Santos MJ; Alzamora AC
    Nitric Oxide; 2012 Feb; 26(2):118-25. PubMed ID: 22265789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
    López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
    Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML
    J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of nitric oxide in exercise sympatholysis.
    Buckwalter JB; Taylor JC; Hamann JJ; Clifford PS
    J Appl Physiol (1985); 2004 Jul; 97(1):417-23; discussion 416. PubMed ID: 15020577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
    McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
    Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of nitric oxide in regulation of gastric acid secretion in rats: effects of NO donors and NO synthase inhibitor.
    Kato S; Kitamura M; Korolkiewicz RP; Takeuchi K
    Br J Pharmacol; 1998 Mar; 123(5):839-46. PubMed ID: 9535011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide synthase inhibition with N omega-nitro-L-arginine methyl ester affects blood pressure and cardiovascular structure in the genetically hypertensive rat strain.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):433-5. PubMed ID: 9171951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of nitric oxide in the cerebrovascular response to hypercapnia.
    Smith JJ; Lee JG; Hudetz AG; Hillard CJ; Bosnjak ZJ; Kampine JP
    Anesth Analg; 1997 Feb; 84(2):363-9. PubMed ID: 9024030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular neural reflexes in L-NAME-induced hypertension in mice.
    Peotta VA; Vasquez EC; Meyrelles SS
    Hypertension; 2001 Sep; 38(3 Pt 2):555-9. PubMed ID: 11566930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system.
    Scrogin KE; Hatton DC; Chi Y; Luft FC
    Am J Physiol; 1998 Feb; 274(2):R367-74. PubMed ID: 9486293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nitric oxide synthase inhibition and low-salt diet on blood pressure and mesenteric resistance artery remodelling in genetically hypertensive rats.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2001 Sep; 28(9):761-3. PubMed ID: 11560124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of N(G)-nitro-L-arginine-methyl ester on neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits.
    Matsumoto M; Iida Y; Wakamatsu H; Ohtake K; Nakakimura K; Xiong L; Sakabe T
    Anesth Analg; 1999 Sep; 89(3):696-702. PubMed ID: 10475308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.